PenPal

Globally, 436 million people live with diabetes. Insulin is a treatment for type 1 and type 2 diabetes.  

PenPal seamlessly connects insulin pens to a smartphone enabling remote monitoring and decision support for people with diabetes.  

PenPal uses patent-pending sensor technology to track the plunger position in the insulin pen.